REPORTS

Let’s Pullulate and Expand Your Business

Monoclonal Antibodies Market - Global Professional Analysis and Forecast to 2026

Oct 12, 2019  |  146 PAGES  |  REPORT CODE: CMM207150
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Monoclonal Antibodies market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 7.5% during the forecast period.

This report presents the market size and development trends by detailing the Monoclonal Antibodies market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Monoclonal Antibodies market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Monoclonal Antibodies industry and will help you to build a panoramic view of the industrial development.

Monoclonal Antibodies Market, By Type:

  • Type 1

  • Type 2

  • Type 3

Monoclonal Antibodies Market, By Application:

  • End-Users 1

  • End-Users 2

  • End-Users 3

Some of the leading players are as follows:

  • Merck

  • Bristol-Myers Squibb

  • Johnson & Johnson

  • ADC Therapeutics, Agensys

  • AbGenomics

  • F. Hoffmann-La Roche

  • ALMAC Group

  • Amgen

  • AbbVie

  • Alexion Pharmaceuticals

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Monoclonal Antibodies Market: Technology Type Analysis

  • 4.1 Monoclonal Antibodies Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Monoclonal Antibodies Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Type 1

    • 4.3.2 Type 2

    • 4.3.3 Type 3

5 Monoclonal Antibodies Market: Product Analysis

  • 5.1 Monoclonal Antibodies Product Market Share Analysis, 2018 & 2026

  • 5.2 Monoclonal Antibodies Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Monoclonal Antibodies Market: Application Analysis

  • 6.1 Monoclonal Antibodies Application Market Share Analysis, 2018 & 2026

  • 6.2 Monoclonal Antibodies Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 End-User 1

    • 6.3.2 End-User 1

    • 6.3.3 End-User 3

7 Monoclonal Antibodies Market: Regional Analysis

  • 7.1 Monoclonal Antibodies Regional Market Share Analysis, 2018 & 2026

  • 7.2 Monoclonal Antibodies Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Merck

    • 9.1.1 Merck Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Bristol-Myers Squibb

    • 9.2.1 Bristol-Myers Squibb Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Johnson & Johnson

    • 9.3.1 Johnson & Johnson Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 ADC Therapeutics, Agensys

    • 9.4.1 ADC Therapeutics, Agensys Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 AbGenomics

    • 9.5.1 AbGenomics Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 F. Hoffmann-La Roche

    • 9.6.1 F. Hoffmann-La Roche Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 ALMAC Group

    • 9.7.1 ALMAC Group Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Amgen

    • 9.8.1 Amgen Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 AbbVie

    • 9.9.1 AbbVie Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 Alexion Pharmaceuticals

    • 9.10.1 Alexion Pharmaceuticals Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

 

The List of Tables and Figures (Totals 84 Figures and 136 Tables)

  • Figure Type 1 Monoclonal Antibodies market, 2015 - 2026 (USD Million)

  • Figure Type 2 Monoclonal Antibodies market, 2015 - 2026 (USD Million)

  • Figure Type 3 Monoclonal Antibodies market, 2015 - 2026 (USD Million)

  • Figure End-Users 1 market, 2015 - 2026 (USD Million)

  • Figure End-Users 2 market, 2015 - 2026 (USD Million)

  • Figure End-Users 3 market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Monoclonal Antibodies market, by country, 2015 - 2026 (USD Million)

  • Table North America Monoclonal Antibodies market, by type, 2015 - 2026 (USD Million)

  • Table North America Monoclonal Antibodies market, by product, 2015 - 2026 (USD Million)

  • Table North America Monoclonal Antibodies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Monoclonal Antibodies market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Monoclonal Antibodies market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Monoclonal Antibodies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Monoclonal Antibodies market, by type, 2015 - 2026 (USD Million)

  • Table Canada Monoclonal Antibodies market, by product, 2015 - 2026 (USD Million)

  • Table Canada Monoclonal Antibodies market, by application, 2015 - 2026 (USD Million)

  • Table Europe Monoclonal Antibodies market, by country, 2015 - 2026 (USD Million)

  • Table Europe Monoclonal Antibodies market, by type, 2015 - 2026 (USD Million)

  • Table Europe Monoclonal Antibodies market, by product, 2015 - 2026 (USD Million)

  • Table Europe Monoclonal Antibodies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Monoclonal Antibodies market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Monoclonal Antibodies market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Monoclonal Antibodies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Monoclonal Antibodies market, by type, 2015 - 2026 (USD Million)

  • Table Germany Monoclonal Antibodies market, by product, 2015 - 2026 (USD Million)

  • Table Germany Monoclonal Antibodies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Monoclonal Antibodies market, by type, 2015 - 2026 (USD Million)

  • Table France Monoclonal Antibodies market, by product, 2015 - 2026 (USD Million)

  • Table France Monoclonal Antibodies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Monoclonal Antibodies market, by type, 2015 - 2026 (USD Million)

  • Table Italy Monoclonal Antibodies market, by product, 2015 - 2026 (USD Million)

  • Table Italy Monoclonal Antibodies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Monoclonal Antibodies market, by type, 2015 - 2026 (USD Million)

  • Table Spain Monoclonal Antibodies market, by product, 2015 - 2026 (USD Million)

  • Table Spain Monoclonal Antibodies market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Monoclonal Antibodies market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Monoclonal Antibodies market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Monoclonal Antibodies market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Monoclonal Antibodies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Monoclonal Antibodies market, by type, 2015 - 2026 (USD Million)

  • Table China Monoclonal Antibodies market, by product, 2015 - 2026 (USD Million)

  • Table China Monoclonal Antibodies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Monoclonal Antibodies market, by type, 2015 - 2026 (USD Million)

  • Table Japan Monoclonal Antibodies market, by product, 2015 - 2026 (USD Million)

  • Table Japan Monoclonal Antibodies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Monoclonal Antibodies market, by type, 2015 - 2026 (USD Million)

  • Table India Monoclonal Antibodies market, by product, 2015 - 2026 (USD Million)

  • Table India Monoclonal Antibodies market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Monoclonal Antibodies market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Monoclonal Antibodies market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Monoclonal Antibodies market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Monoclonal Antibodies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Monoclonal Antibodies market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Monoclonal Antibodies market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Monoclonal Antibodies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Monoclonal Antibodies market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Monoclonal Antibodies market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Monoclonal Antibodies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Monoclonal Antibodies market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Monoclonal Antibodies market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Monoclonal Antibodies market, by application, 2015 - 2026 (USD Million)

  • Table MEA Monoclonal Antibodies market, by country, 2015 - 2026 (USD Million)

  • Table MEA Monoclonal Antibodies market, by type, 2015 - 2026 (USD Million)

  • Table MEA Monoclonal Antibodies market, by product, 2015 - 2026 (USD Million)

  • Table MEA Monoclonal Antibodies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Monoclonal Antibodies market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Monoclonal Antibodies market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Monoclonal Antibodies market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Monoclonal Antibodies market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Monoclonal Antibodies market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Monoclonal Antibodies market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Merck Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Bristol-Myers Squibb Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Johnson & Johnson Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table ADC Therapeutics, Agensys Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table AbGenomics Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table F. Hoffmann-La Roche Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table ALMAC Group Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Amgen Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table AbbVie Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Alexion Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$4840
$9680
BUY NOWClick MeBUY NOW
top